Complementation of human immunodeficiency virus glycoprotein mutations in trans
- PMID: 1645136
- DOI: 10.1099/0022-1317-73-8-1907
Complementation of human immunodeficiency virus glycoprotein mutations in trans
Abstract
The external glycoproteins of human immunodeficiency virus type 1 (HIV-1) (gp120) and HIV-2 (gp105) are responsible for binding the cellular receptor CD4. The proteins are functionally identical although their affinity for CD4 varies, with gp120 binding 10- to 20-fold more efficiently than gp105. To investigate the structural requirements for CD4 binding in each molecule we have constructed a number of hybrid glycoproteins in which sequences are exchanged between the two molecules via conserved residues and subsequently tested for their ability to bind to CD4. We found that two constructs in which the V1/V2 or V3 loops of gp105 are exchanged for those of gp120 continue to bind to CD4. Surprisingly, however, all other domain exchange mutants failed to bind to CD4 suggesting that long-range interactions within the molecule are sequence-specific. Mixing mutant molecules in vitro did not rescue CD4 binding. However, co-expression of a number of mutant glycoprotein pairs within the same cell produced complementation of CD4 binding ability; complementing molecules were shown to be heteromeric in structure. Alignment of the molecules within each complementation group allowed the interactive sequences necessary for receptor binding to be determined. These sequences constitute a novel target for the disruption of gp120 function.
Similar articles
-
Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.Virology. 1996 Apr 1;218(1):224-31. doi: 10.1006/viro.1996.0182. Virology. 1996. PMID: 8615025
-
Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):427-36. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7697438
-
Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus.Virology. 1995 Jul 10;210(2):448-55. doi: 10.1006/viro.1995.1361. Virology. 1995. PMID: 7618279
-
CD4 activation of HIV fusion.Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review.
-
Ligand-receptor engineering and its application towards the complementation of genetic disease and target identification.Curr Top Med Chem. 2005;5(4):413-20. doi: 10.2174/1568026053828420. Curr Top Med Chem. 2005. PMID: 15892683 Review.
Cited by
-
Immunogenicity of the outer domain of a HIV-1 clade C gp120.Retrovirology. 2007 May 17;4:33. doi: 10.1186/1742-4690-4-33. Retrovirology. 2007. PMID: 17509143 Free PMC article.
-
Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.J Virol. 1993 Jan;67(1):150-60. doi: 10.1128/JVI.67.1.150-160.1993. J Virol. 1993. PMID: 8093218 Free PMC article.
-
Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.J Virol. 2004 Feb;78(3):1525-39. doi: 10.1128/jvi.78.3.1525-1539.2004. J Virol. 2004. PMID: 14722307 Free PMC article.
-
Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus.J Virol. 1995 Feb;69(2):1256-60. doi: 10.1128/JVI.69.2.1256-1260.1995. J Virol. 1995. PMID: 7815501 Free PMC article.
-
Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin.J Virol. 1993 Jun;67(6):3601-4. doi: 10.1128/JVI.67.6.3601-3604.1993. J Virol. 1993. PMID: 8497067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
